An overview of cervical cancer epidemiology and prevention in the Baltic States

[1] Vaccarella S(2013)Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors Eur J Cancer 49 3262-73

[2] Lortet-Tieulent J(2021)Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: a model-based analysis Prev Med 144 106276-27

[3] Plummer M(2019)The projected timeframe until cervical cancer elimination in Australia: a modelling study The Lancet Public health 4 19-22

[4] Portnoy A(2020)Projected time to elimination of cervical cancer in the USA: a comparative modelling study Lancet Public Health 5 213-9

[5] Pedersen K(2019)Is a delay in the introduction of human papillomavirus-based cervical screening affordable? J Med Screen 26 44-203

[6] Trogstad L(2020)Cervical Cancer mortality in East-Central European Countries Int J Environ Res Public Health 17 4639-81

[7] Hall MT(2020)Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis The Lancet Global health 8 191-80

[8] Simms KT(2010)Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia BMC Infect Dis 10 63-91

[9] Lew JB(2007)Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union J Med Virol 79 771-92

[10] Burger EA(2006)Prevalence and risk factors of HPV infection among high-risk rural and urban lithuanian women Gynecol Obstet Invest 62 173-70

[1] Vaccarella S(2013)Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors Eur J Cancer 49 3262-73

[2] Lortet-Tieulent J(2021)Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: a model-based analysis Prev Med 144 106276-27

[3] Plummer M(2019)The projected timeframe until cervical cancer elimination in Australia: a modelling study The Lancet Public health 4 19-22

[4] Portnoy A(2020)Projected time to elimination of cervical cancer in the USA: a comparative modelling study Lancet Public Health 5 213-9

[5] Pedersen K(2019)Is a delay in the introduction of human papillomavirus-based cervical screening affordable? J Med Screen 26 44-203

[6] Trogstad L(2020)Cervical Cancer mortality in East-Central European Countries Int J Environ Res Public Health 17 4639-81

[7] Hall MT(2020)Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis The Lancet Global health 8 191-80

[8] Simms KT(2010)Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia BMC Infect Dis 10 63-91

[9] Lew JB(2007)Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union J Med Virol 79 771-92

[10] Burger EA(2006)Prevalence and risk factors of HPV infection among high-risk rural and urban lithuanian women Gynecol Obstet Invest 62 173-70